Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice - Inhibition of 2 independent cellular cholesterol-releasing pathways in vivo

被引:32
作者
Tomimoto, S
Tsujita, M
Okazaki, M
Usui, S
Tada, T
Fukutomi, T
Ito, S
Itoh, M
Yokoyama, S
机构
[1] Nagoya City Univ, Sch Med, Dept Biochem 1, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Sch Med, Dept Internal Med 1, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[3] Nagoya City Univ, Sch Nursing, Dept Pathol, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[4] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Chem Lab, Ichikawa, Japan
[5] Tokyo Med & Dent Univ, Sch Allied Hlth Sci, Tokyo, Japan
关键词
high density lipoproteins; lecithin-cholesterol acyltransferase; cholesterol efflux; cholesterol homeostasis; probucol;
D O I
10.1161/01.ATV.21.3.394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice hut not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.
引用
收藏
页码:394 / 400
页数:7
相关论文
共 33 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]  
Assmann G, 1995, METABOLIC MOL BASES, P2053
[3]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[4]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[5]   Antiatherogenic effects of the antioxidant BO-653 in three different animal models [J].
Cynshi, O ;
Kawabe, Y ;
Suzuki, T ;
Takashima, Y ;
Kaise, H ;
Nakamura, M ;
Ohba, Y ;
Kato, Y ;
Tamura, K ;
Hayasaka, A ;
Higashida, A ;
Sakaguchi, H ;
Takeya, M ;
Takahashi, K ;
Inoue, K ;
Noguchi, N ;
Niki, E ;
Kodama, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10123-10128
[6]   Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange [J].
Czarnecka, H ;
Yokoyama, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2023-2028
[7]  
CZARNECKA H, 1993, J BIOL CHEM, V268, P19334
[8]   DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE [J].
FRANCIS, GA ;
KNOPP, RH ;
ORAM, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :78-87
[9]  
GLOMSET JA, 1968, J LIPID RES, V9, P155
[10]  
GLOMSET JA, 1995, METABOLIC MOL BASIS, V2, P1933